CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Sawai Pharmaceutical Co., Ltd. et al. vs. Astellas Pharma Inc.

Explore the PTAB proceeding IPR2018-00079 filed by Sawai Pharmaceutical Co., Ltd. et al. on 2017-10-16. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2018-00079

Filing Date

2017-10-16

Accorded Filing Date

2017-10-16

Institution Decision Date

2018-05-04

Last Modified Date

2022-10-10

Proceeding Type

IPR

Termination Date

β€”

Trial Status

Institution Denied

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 09529096
Respondent Patent Number 6346532
Legal Expiration Date
2022-03-27 Expired (Term Ended)
Patent Term Adjustment (PTA) +1259 Days Awarded
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

0 Total

Proceeding Status

Institution Denied

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 3 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): πŸ‡―πŸ‡΅ Japan πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (3 found):
U.S. Courts: 3
U.S. District Court 2023-06-09
1:23-cv-00629

Astellas Pharma Inc. v. Evitalin LLC

Asserted Patent
Status: DED
U.S. District Court 2016-10-17
1:16-cv-00954

Astellas Pharma Inc. v. Sawai Pharmaceutical Co., Ltd.

Asserted Patent
Status: DED
U.S. District Court 2016-10-06
1:16-cv-00905

Astellas Pharma Inc. v. Actavis Elizabeth LLC

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

41
9

Decision Granting Joint Motion to Terminate Proceeding Paper

2018-06-01 FILING PARTY: None
8

Joint Motion to Terminate Paper

2018-05-29 FILING PARTY: None
7

Trial Instituted Document Paper

2018-05-04 FILING PARTY: None
2003

Myrbetriq: Mechanism of Action Exhibits

2018-02-08 FILING PARTY: None
2005

WO97/16189 Exhibits

2018-02-08 FILING PARTY: None

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc